CVD care with Grant W Reed | Radcliffe Cardiology

27: The New Reality of CVD Care With Grant W Reed, Director of the Cleveland Clinic’s STEMI Program

Average (ratings)

No ratings

•

Your rating

The State of Ohio reported its first coronavirus cases on March 9. Prior to that, on February 28, the Cleveland Clinic announced that they are prepared to open 1,000 additional hospital beds if needed. Ohio was one of the states to follow recommendations and intervene quickly.

Ankur Kalra asks Grant W Reed, Director of the Cleveland Clinic’s STEMI program, to reflect on the actions they took and the challenges of delaying cardiovascular procedures in the wake of the coronavirus pandemic. Dr Reed offers insight on the factors that influenced the Cleveland Clinic’s STEMI policy for COVID-19. Ankur and Grant discuss the triage considerations for patients with structural heart disease and the steps the clinic took to protect its healthcare workers.

In this week’s Parallax Dr Kalra and Dr Reed are addressing questions in the wake of Cleveland Clinic’s decision to reopen services for essential procedures. Which cardiac operations should be performed? What is the impact of COVID-19 outbreak on cardiac surgery? How can healthcare institutions address the safety concerns of their patients?

Tune in to listen to this week’s episode of Parallax. Hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.
Submit your questions to Ankur via: podcast@radcliffe-group.com.

interventions.onlinejacc.org/content/ea…020.04.001

Read MoreRead Less

Episodes

Up Next

28: Unified Pathways for Treating Structural Heart Disease: Anmar Kanaa’N & Joseph Lahorra

EP28 • Apr 23, 2020 • 37m 35s

Heart surgery is not the best option for every patient suffering from structural heart disease. This was recognized by interventional cardiologist Anmar Kanaa’N and cardiac surgeon Joseph Lahorra who decided to unify their skillsets and bring the Structural Heart Program to life. Their vision was to offer patients with heart valve diseases all available options at Cleveland Clinic’s Akron General.

In this week’s Parallax, Dr Kanaa’N, the director of the program, and Dr Lahorra, chairman of the Heart, Vascular & Thoracic Department of Akron General introduce the listeners to the foundations of their program and the paradigm shift brought by TAVR.

All Episodes

02: Role Of High-Sensitivity Cardiac Troponin In ACS

EP02 • Apr 23, 2020 • 29m 55s

Ankur is back with his second #AudioArticle! This week he spoke with Santiago Garcia from the Minneapolis Heart Institute about Santiago’s US Cardiology Review 13.1 article on the role of high-sensitivity cardiac troponin (hscTn) assays and their ability to rapidly rule in or rule out acute coronary syndrome (ACS) with improved sensitivity.

Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER.

Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger

EP01 • Apr 23, 2020 • 27m 44s

In our first episode, Ankur explains his vision for and inspiration to start ‘Parallax’, and speaks with Chad Kliger from Lenox Hill Hospital in New York about conduction abnormalities after transcatheter aortic valve replacement (TAVR/TAVI), a review article published in US Cardiology Review 13.1 Ankur and Chad look at conduction abnormalities after TAVR/TAVI with a focus on basic conduction system anatomy in relation to the aortic valve, the mechanism, incidence, predisposing factors for occurrence, impact on mortality and finally, proposed treatment algorithms for management. Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.

... 5 6 7 8 9 10 11 12 13

... 11 12 13

EP 107: JACC: Advances - Leadership & the Future of Publishing with Dr Silversides

EP107 • Feb 12, 2024 • 43m 21s

Dive into the unique synergy between her clinical practice and editorial leadership as Dr Silversides shares her vision for the journal. Learn how she navigates diverse responsibilities, manages peer reviews, and ensures fair evaluation of the submitted manuscripts. Get insights into launching a journal, from adapting to the needs of the readership and editorial board selection to time management. Dr Silversides joins Dr Kalra in exploring the evolving landscape of academic publishing, discussing the challenges and opportunities presented by AI and other advancements.

EP 106: Transforming Health Systems Through Economics with Dr Alex Carter

EP106 • Jan 29, 2024 • 47m

The podcast embarks on an exploration of the program's three fundamental pillars: health economics, outcomes measurement, and management. Dr. Carter underscores the importance of efficiently allocating scarce resources, evaluating health system performance through population outcomes, and translating theoretical knowledge into practical application through leadership.

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

EP105 • Dec 19, 2023 • 1h 3m 40s

Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.

EP 104: Caring for All Hearts: Disparities in Care with Dr Anuradha Lala

EP104 • Dec 04, 2023 • 44m 2s

In this thought-provoking episode, Dr Ankur Kalra is joined by Dr Anuradha Lala. They delve into the critical topic of disparities in care within the healthcare system from a cardiologist's point of view and explore actionable steps towards a more inclusive and fair healthcare landscape.

This series is supported by ZOLL and is intended for Health Care Professionals.

EP 103: CCS-AMI: New Classification for Acute Myocardial Infarction with Dr Kumar

EP103 • Oct 30, 2023 • 42m 43s

In this informative episode, Dr Kumar shares what led his team and the CCS to introduce a new classification scheme for acute MI. He discusses how research from the past 15 years highlighted the need to incorporate tissue changes resulting from acute myocardial infarction (MI) into clinical practice. Dr Kumar outlines the four stages of CCS-AMI, and we gain insight into how this novel classification scheme could impact bedside medicine.

... 2 3 4 5 6 7 ...

... 3 4 5 ...